CD36 and cancer: CD36 has been identified as a new promising therapeutic target for cancer, since it strengthens metastasis initiation potential of cancer cells and upon blocking its lipid uptake activity, with a CD36 specific antibody, the size of lymph node metastases is reduced by 80–90%29.